Literature DB >> 24424345

Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata.

Misao Takemoto1, Yumi Kawamura2, Mikako Hirohama3, Yuki Yamaguchi4, Hiroshi Handa5, Hisato Saitoh6, Yoichi Nakao7, Manabu Kawada8, Khan Khalid9, Hiroyuki Koshino10, Ken-ichi Kimura2, Akihiro Ito11, Minoru Yoshida12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24424345     DOI： 10.1038/ja.2013.142

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  18 in total

1.  Inhibition of protein SUMOylation by natural quinones.

Authors:  Isao Fukuda; Mikako Hirohama; Akihiro Ito; Mohammad Tariq; Yasuhiro Igarashi; Hisato Saitoh; Minoru Yoshida
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

2.  LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Authors:  Gretchen L Bentz; Charles Randall Moss; Christopher B Whitehurst; Cary A Moody; Joseph S Pagano
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

Review 3.  Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases.

Authors:  Jin-Taek Hwang; Ahyoung Lee; Changwon Kho
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

4.  Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.

Authors:  Xingyue He; Jessica Riceberg; Teresa Soucy; Erik Koenig; James Minissale; Melissa Gallery; Hugues Bernard; Xiaofeng Yang; Hua Liao; Claudia Rabino; Pooja Shah; Kristina Xega; Zhong-Hua Yan; Mike Sintchak; John Bradley; He Xu; Matt Duffey; Dylan England; Hirotake Mizutani; Zhigen Hu; Jianping Guo; Ryan Chau; Lawrence R Dick; James E Brownell; John Newcomb; Steve Langston; Eric S Lightcap; Neil Bence; Sai M Pulukuri
Journal:  Nat Chem Biol       Date:  2017-09-11       Impact factor: 15.040

Review 5.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

Review 6.  SUMOylation in brain ischemia: Patterns, targets, and translational implications.

Authors:  Joshua D Bernstock; Wei Yang; Daniel G Ye; Yuntian Shen; Stefano Pluchino; Yang-Ja Lee; John M Hallenbeck; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-17       Impact factor: 6.200

7.  Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Authors:  Peter Garcia; Abigail Harrod; Shruti Jha; Jessica Jenkins; Alex Barnhill; Holden Lee; Merritt Thompson; Jordan Pringle Williams; James Barefield; Ashton Mckinnon; Persia Suarez; Ananya Shah; Angela J Lowrey; Gretchen L Bentz
Journal:  Antiviral Res       Date:  2021-02-10       Impact factor: 5.970

8.  A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver.

Authors:  Miyuki Suzawa; Diego A Miranda; Karmela A Ramos; Kenny K-H Ang; Emily J Faivre; Christopher G Wilson; Laura Caboni; Michelle R Arkin; Yeong-Sang Kim; Robert J Fletterick; Aaron Diaz; John S Schneekloth; Holly A Ingraham
Journal:  Elife       Date:  2015-12-11       Impact factor: 8.140

Review 9.  SUMO wrestling with Ras.

Authors:  Haibo Zhang; Ji Luo
Journal:  Small GTPases       Date:  2016-04-08

Review 10.  Current Status of SUMOylation Inhibitors.

Authors:  Christopher M Brackett; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.